Immunoglobulin G4-related hypertrophic pachymeningitis
A case-oriented review
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 24, 2019
- Accepted in final form March 12, 2019
- First Published May 7, 2019.
Author Disclosures
- Michaël Levraut, MD,
- Mikaël Cohen, MD,
- Saskia Bresch, MD,
- Caroline Giordana, MD,
- Fanny Burel-Vandenbos, MD, PhD,
- Lydiane Mondot, MD,
- Jacques Sedat, MD,
- Denys Fontaine, MD, PhD,
- Véronique Bourg, MD,
- Nihal Martis, MD and
- Christine Lebrun-Frenay, MD, PhD
- Michaël Levraut, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mikaël Cohen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Dr Cohen received honoraria and consulting fees from Biogen, Merck Serono, Sanofi Genzyme, Novartis, Roche and Ad Scientiam
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Saskia Bresch, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Caroline Giordana, MD,
Abbvie
NONE
Travel and speaker honoraria from Abbvie
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fanny Burel-Vandenbos, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lydiane Mondot, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jacques Sedat, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Denys Fontaine, MD, PhD,
Medtronic
NONE
(1) Medtronic, speaker honoraria, (2) St Jude Medical, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medtronic, (2) St Jude Medical
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Véronique Bourg, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nihal Martis, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christine Lebrun-Frenay, MD, PhD
serving on a scientific advisory board from Biogen, Novartis, Merck, Genzyme,Teva, Roche
NONE
Funding for travel or speaker honoraria from Biogen, Merck, Genzyme, Roche
Serving as editorial advisory board member for Revue Neurologique (Paris) Elsevier, Neurology and therapy.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
UT Southwestern, Dallas, TX. Clinical advisor and senior professor.
Franch MS Society (SFSEP) EDMUS (OFSEP Center) Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the Service de Médecine Interne (M.L., N.M.), Hôpital l'Archet 1, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur; Service de Cytologie Pathologique (F.B.-V.), Hôpital l'Archet 1, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur; and Service de Neurologie (M.C., S.B., C.G., V.B., C.L.-F.), Service de Radiologie (L.M.), Service de Radiologie Interventionnelle (J.S.), and Service de Neurochirurgie (D.F.), Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, France.
- Correspondence
Dr. Levraut michael.levraut{at}gmail.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Clinical/Scientific Notes
A Case of Definite IgG4-Related PachymeningitisA. Kosakai, D. Ito, S. Yamada et al.Neurology, October 11, 2010 -
Clinical/Scientific Notes
Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximabBing Liao, Carlos Kamiya-Matsuoka, Xiang Fang et al.Neurology - Neuroimmunology Neuroinflammation, October 29, 2014 -
Article
Immunoglobulin G4-related pathologic features in inflammatory neuropathiesKen Ohyama, Haruki Koike, Mie Takahashi et al.Neurology, September 25, 2015 -
Clinical/Scientific Notes
IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodiesJennifer Massey et al.Neurology: Neuroimmunology & Neuroinflammation, March 16, 2017